Are extracellular matrix components altered in the hippocampus , cortex , and cerebrospinal fluid of patients with mesial temporal lobe epilepsy?
These results suggest that these matrix components could be involved in the pathophysiology of TLE.
Survivors of lobar ICH with atrial fibrillation should not be offered long-term anticoagulation. Similarly, most patients with deep hemispheric ICH and atrial fibrillation should not receive anticoagulant therapy. However, patients with deep hemispheric ICH at particularly high risk for thromboembolic stroke or low risk of ICH recurrence might benefit from long-term anticoagulation.